-
Life science M&A activity reached $357bn in 2019, report finds
europeanpharmaceuticalreview
January 15, 2020
According to new research, M&As within the life science industry reached a high last year and is expected to continue its growth in 2020.
-
Sartorius Establishes Scientific Advisory Board
b3cnewswire
December 25, 2019
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, today announced that it established a Scientific Advisory Board for its Corporate Research activities.
-
Epidarex Exeed Founded by Epidarex Capital to Advance Early Stage, Highly Innovative Life Science Assets
firstwordpharma
December 10, 2019
Epidarex Capital, a leading transatlantic venture fund, announced the launch of its therapeutic discovery engine, Epidarex Exeed Ltd. (Exeed).
-
Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)
worldpharmanews
February 18, 2019
Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology...
-
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
b3cnewswire
February 15, 2019
Andrew Alliance S.A. and Sartorius today announced the launch of the Andrew Alliance Pipette+ system, which uniquely provides both full traceability and improved repeatability in manual pipetting for life science laboratories....
-
Post-Monsanto Era of Bayer Group: To Lay off 10,000+ Employees, Scale Back Business, and Develop Life Science
PharmaSources/Youyi
January 08, 2019
Bayer formally acquired the U.S. agricultural company: Monsanto for a price of USD63 billion on June 7, 2018 upon approval of the relevant U.S. and European regulators.
-
UCB to spend £200M to create U.K. R&D hub
fiercebiotech
January 02, 2019
UCB is set to spend up to £200 million ($255 million) to create a new R&D facility in the U.K. The British government unveiled UCB’s investment in its second life science sector deal, which disclosed total spending of £1.3 billion.....
-
Suven Life Science gets neuro patent from India, Japan
expressbpd
September 26, 2017
Drug firm Suven Life Sciences has been granted a patent each by India and Japan for a drug used in the treatment of neuro-degenerative diseases.
-
Cyber attacks top digital risk for life science companies
europeanpharmaceuticalreview
July 19, 2017
Digital risk calculator highlights cyber attacks and highly sensitive or valuable data as major risks for life sciences businesses
-
Merck KGaA refines Western European life science production site network
cphi-online
July 17, 2017
Company to invest €90 million and cut 200 jobs.